openPR Logo
Press release

Polycystic Ovarian Syndrome Treatment Market Size To Reach USD 4.18 Billion, Globally, By 2026 | Novartis AG, Pfizer Inc.

06-16-2021 02:24 PM CET | Health & Medicine

Press release from: Allied Market Research

Polycystic Ovarian Syndrome Treatment Market

Polycystic Ovarian Syndrome Treatment Market

UPDATE AVAILABLE ON-DEMAND

Polycystic ovarian syndrome or PCOS is a hormonal disorder that occurs in women during their childbearing age and is characterized by formation of cyst on ovaries.

The global polycystic ovarian syndrome treatment market size was valued at $2,902 million in 2018, and is projected to reach $4,184 million by 2026, growing at a CAGR of 4.7% from 2019 to 2026.

Download Free Report Sample @ https://www.alliedmarketresearch.com/request-sample/6314

COVID-19 scenario-

1) Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics.

2) However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations.

3) Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products.

PCOS often leads to hirsutism, obesity, infertility, and diabetes, thus, needs effective management. Presently, there is no cure for PCOS, but different types of medications, such as insulin sensitizing agent, oral contraceptive, antiandrogens, and anti-obesity drugs are used to manage PCOS.

The polycystic ovarian syndrome treatment market is expected to experience significant growth during the forecast period owing to rise in demand for PCOS treatment medication across different regions and increase in popularity combination therapy majorly drives the market growth. Increase in prevalence of PCOS is expected to further boost the polycystic ovarian syndrome treatment market growth during the forecast period. In addition, significant unmet need for PCOS treatment, increase in R&D activities to develop PCOS therapeutics, and growing demand forof PCOS therapeutics in developing countries further creates opportunities for the PCOS treatment market. However, lack of approved drugs and adverse effects associated with off label drugs are anticipated to hamper the market growth.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6314

On the basis of drug class, the market is categorized into insulin sensitizing agent, oral contraceptive, antiandrogens, anti-obesity drugs, and others. Presently, the insulin sensitizing agent segment is the major revenue contributing segment and is estimated to show a significant market growth during the forecast period, owing to higher adoption of insulin sensitizing agents as first line treatment in the management of PCOS.

According to distribution channel, the polycystic ovarian syndrome treatment market is classified into hospital pharmacies, drug stores & retail pharmacies, and online providers. The online providers segment is anticipated to depict significant growth during the forecast period, attributed to the rise in preference for online purchasing of drugs over traditional methods, increase in awareness of online pharmacy, and rise in number of internet users.

North America accounted for approximately one-half of the global polycystic ovarian syndrome treatment market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the rise in adoption of polycystic ovarian syndrome treatment medications, well developed healthcare infrastructure, large number of target population with higher health awareness, wide availability of advanced polycystic ovarian syndrome treatment therapeutics, and supportive reimbursement policies in the healthcare system. In addition, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growing prevalence of PCOS, and increase in the adoption of polycystic ovarian syndrome treatment medication for the same.

Access Full Report @ https://www.alliedmarketresearch.com/polycystic-ovarian-syndrome-treatment-market-A05949

The Major Key Players Are:

• Allergan plc.
• AstraZeneca plc.
• Bayer AG
• Bristol-Myers Squibb Company
• Johnson and Johnson
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• SANOFI
• Teva Pharmaceutical Industries.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Polycystic Ovarian Syndrome Treatment Market Size To Reach USD 4.18 Billion, Globally, By 2026 | Novartis AG, Pfizer Inc. here

News-ID: 2306714 • Views: 289

More Releases from Allied Market Research

Carbon Fiber Tape Market Statistics, Regional Analysis by Key Players | Industry …
Allied Market Research published a new report, titled, “Carbon Fiber Tape Market.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The report offers key
Valeric Acid Market Overview With Detailed Analysis, Competitive Landscape, Fore …
Allied Market Research published a new report, titled, “Valeric Acid Market.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The report offers key drivers
Zabuyelite Market Development Strategy, Sales Revenue, Opportunities and Challen …
Allied Market Research published a new report, titled, ” Zabuyelite Market.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The report offers key drivers
Sodium Lactate Market Analysis of Major Segments and Future Opportunity Assessme …
Allied Market Research published a new report, titled, “Sodium Lactate Market.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. The report offers key drivers

All 5 Releases


More Releases for PCOS

Global Polycystic Ovary Syndrome (PCOS) Market Research and Forecast 2018-2023
Global polycystic ovary syndrome market size, share, market trends, research and analysis report by diagnosis (ultrasound, pelvic exam, blood test) by treatment (ovarian wedge resection, laparoscopic ovarian drilling, acupuncture) forecast 2018-2023 According to the OMR analysis, the global polycystic ovarian syndrome is growing at a significant rate during 2018-2023. The global polycystic ovarian syndrome has been growing significantly due to initiatives taken by the government authorities regarding early diagnosis of the
Global Polycystic Ovary Syndrome (PCOS) Drugs Market to Reach US$ 1,154.8 Mn by …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers
Global Polycystic Ovary Syndrome (PCOS) Drugs Market to Reach US$ 1,154.8 Mn by …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovary Syndrome (PCOS) Drugs Market 2018: BIOCAD, Merck KGaA, AstraZen …
Qyresearchreports include new market research report “2018-2025 Polycystic Ovary Syndrome (PCOS) Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications” to its huge collection of research reports. The global Polycystic Ovary Syndrome (PCOS) Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017
Polycystic Ovary Syndrome (PCOS) Treatment Market Presume to Surge at CAGR 4.6% …
According to the latest market report published by Persistence Market Research titled ‘Polycystic Ovary Syndrome Drugs Market: Global Industry Analysis and Forecast, 2016–2024’, the global polycystic ovary syndrome drugs market is expected to register a CAGR of 4.6% during the forecast period 2016–2024 and is expected to expand 1.5x in terms of revenue by 2024. The report analyzes the global PCOS drugs market performance and provides information on key drivers